DRI officials seize 119.4 kg of Alprazolam worth Rs. 23.88 crore

New Delhi:  The officers of Directorate of Revenue Intelligence from Hyderabad, Visakhapatnam, Vijayawada and Kakinada executed a swift and well-coordinated operation resulting in seizure of 119.4 kg Alprazolam in lumpy form, valued at approximately Rs. 23.88 crore in the illicit market, along with 87.8 kg in-process material. The DRI officials also apprehended eight persons involved in illegal manufacturing and distribution of Alprazolam, including the master-mind, chemists, financiers and the buyers at the same place.

After developing a specific intelligence that a few persons were clandestinely manufacturing ‘Alprazolam’ — a psychotropic substance under the NDPS Act, 1985 — at a facility in Atchutapuram, Anakapalli District, Andhra Pradesh, the DRI officials meticulously planned the operation to arrest the entire set of persons involved in manufacturing and distribution of Alprazolam.

Additionally, 3,600 litres in liquid form and 311.6 kg in solid form of illegally procured raw materials, equipment (two reactors, one centrifuge and one drier) used for manufacturing Alprazolam and few incriminating documents were seized to aid further investigation.

All the eight accused persons were arrested and remanded to judicial custody. It is noteworthy that most of the arrested individuals have prior involvement in cases related to the clandestine manufacture of narcotic drugs and psychotropic substances and other criminal activities (murder, cyber-crimes and economic offences).

Initial interrogation revealed that these individuals conspired to undertake this illegal activity, having formed their network during their time in jail, underscoring the deep-rooted and organized nature of the syndicate. The said Alprazolam was intended for transport to Telangana for adulterating Toddy.

Further investigation in the case is in progress.

Related Posts

DCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central Approval

New Delhi — India’s top drug regulator has issued a nationwide alert over 90 fixed-dose combination (FDC) drugs being manufactured and sold without mandatory central approval, directing all state and…

India’s drug body flags 90 unapproved FDC medicines, states told to take action

The Central Drugs Standard Control Organisation (CDSCO), India’s top drug regulator, has identified at least 90 unapproved fixed-dose combination (FDC) medicines in circulation and asked states to move against those…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Ship of Domestic Medical Device Industry flounders, thanks to Israel-Iran War

Ship of Domestic Medical Device Industry flounders, thanks to Israel-Iran War

DCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central Approval

DCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central Approval

India’s drug body flags 90 unapproved FDC medicines, states told to take action

India’s drug body flags 90 unapproved FDC medicines, states told to take action

India advancing as a global hub of affordable, quality healthcare solutions: Dr Jitendra Singh

India advancing as a global hub of affordable, quality healthcare solutions: Dr Jitendra Singh

Unapproved drops for dry eyes pose risks: Govt

Unapproved drops for dry eyes pose risks: Govt

Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?